Improving Mobility After Revascularization in Peripheral Artery Disease
Public ClinicalTrials.gov record NCT06686121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD Trial
Study identification
- NCT ID
- NCT06686121
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Northwestern University
- Other
- Enrollment
- 386 participants
Conditions and interventions
Conditions
Interventions
- Attention Control Behavioral
- Home Based Exercise Behavioral
- Nitrate Rich Beetroot Juice Drug
- Placebo Beetroot Juice Without Nitrate Drug
Behavioral · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 3, 2025
- Primary completion
- Jan 31, 2032
- Completion
- Jul 31, 2032
- Last update posted
- Aug 25, 2025
2025 – 2032
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724 | Not yet recruiting |
| Rancho Research Institute | Downey | California | 90242 | Recruiting |
| Emory University School of Medicine | Atlanta | Georgia | 30307 | Not yet recruiting |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | Recruiting |
| University of Chicago | Chicago | Illinois | 60637 | Recruiting |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03766 | Not yet recruiting |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06686121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06686121 live on ClinicalTrials.gov.